PL337723A1 - Inhalable tocopherol-stabilised prolyposomic powders - Google Patents

Inhalable tocopherol-stabilised prolyposomic powders

Info

Publication number
PL337723A1
PL337723A1 PL98337723A PL33772398A PL337723A1 PL 337723 A1 PL337723 A1 PL 337723A1 PL 98337723 A PL98337723 A PL 98337723A PL 33772398 A PL33772398 A PL 33772398A PL 337723 A1 PL337723 A1 PL 337723A1
Authority
PL
Poland
Prior art keywords
prolyposomic
inhalable
stabilised
tocopherol
powders
Prior art date
Application number
PL98337723A
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PL337723A1 publication Critical patent/PL337723A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
PL98337723A 1997-06-27 1998-06-08 Inhalable tocopherol-stabilised prolyposomic powders PL337723A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Publications (1)

Publication Number Publication Date
PL337723A1 true PL337723A1 (en) 2000-08-28

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337723A PL337723A1 (en) 1997-06-27 1998-06-08 Inhalable tocopherol-stabilised prolyposomic powders

Country Status (18)

Country Link
EP (1) EP1001749A1 (en)
JP (1) JP2002510311A (en)
KR (1) KR20010014163A (en)
CN (1) CN1260713A (en)
AU (1) AU729100B2 (en)
BR (1) BR9810280A (en)
CA (1) CA2295028A1 (en)
EE (1) EE9900601A (en)
HU (1) HUP0003207A3 (en)
ID (1) ID23192A (en)
IL (1) IL133478A0 (en)
IS (1) IS5304A (en)
NO (1) NO996439L (en)
NZ (1) NZ501672A (en)
PL (1) PL337723A1 (en)
SK (1) SK184899A3 (en)
TR (1) TR199903271T2 (en)
WO (1) WO1999000111A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138310A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138311A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
NZ563373A (en) * 2005-06-09 2012-06-29 Meda Ab Method and composition for treating inflammatory disorders
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
KR102339146B1 (en) * 2013-05-06 2021-12-15 디에스엠 아이피 어셋츠 비.브이. Powderous vitamin e formulation
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
CN105078963B (en) * 2015-09-29 2018-06-22 中山大学 Alpha-tocopherol is preparing the application in treating snail fever drug
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation

Also Published As

Publication number Publication date
KR20010014163A (en) 2001-02-26
JP2002510311A (en) 2002-04-02
EE9900601A (en) 2000-08-15
NO996439L (en) 2000-02-28
AU7945698A (en) 1999-01-19
NZ501672A (en) 2001-06-29
EP1001749A1 (en) 2000-05-24
AU729100B2 (en) 2001-01-25
IS5304A (en) 1999-12-15
ID23192A (en) 2000-03-23
HUP0003207A3 (en) 2001-03-28
CA2295028A1 (en) 1999-01-07
TR199903271T2 (en) 2000-08-21
BR9810280A (en) 2000-09-12
HUP0003207A2 (en) 2001-02-28
CN1260713A (en) 2000-07-19
IL133478A0 (en) 2001-04-30
NO996439D0 (en) 1999-12-23
SK184899A3 (en) 2000-05-16
WO1999000111A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
US5797392C1 (en) Inhaler
GB9626263D0 (en) Powder inhaler
PL334447A1 (en) Inhaler
PL335799A1 (en) Inhaler
PL335690A1 (en) Inhaler
PL335701A1 (en) Inhaler
AU135548S (en) Inhaler
AU135120S (en) Inhaler
AU5889398A (en) Powder inhaler
GB2318737B (en) Improved inhalers
HUP0001799A3 (en) Dry powder inhaler
PL327616A1 (en) Inhaler
HUP9901316A3 (en) Inhaler
IL141821A0 (en) Inhaler
ZA976137B (en) Powder atomizer
IL116459A0 (en) Powder formulations
AU135340S (en) An inhaler
GB2312379B (en) Improved inhalers
GB9826783D0 (en) Inhalation powders
PL337723A1 (en) Inhalable tocopherol-stabilised prolyposomic powders
EP1026124A4 (en) Composite powder
GB2320900B (en) Inhalers
GB2310370B (en) Inhaler carrying aid
EP1044161A4 (en) Solid particle manufacture
GB2329582B (en) Powder Puff